Annual Net Income
-$61.29 M
+$154.69 M+71.62%
December 31, 2023
Summary
- As of February 22, 2025, ACAD annual net profit is -$61.29 million, with the most recent change of +$154.69 million (+71.62%) on December 31, 2023.
- During the last 3 years, ACAD annual net income has risen by +$220.30 million (+78.24%).
- ACAD annual net income is now -504.82% below its all-time high of $15.14 million, reached on December 31, 2010.
Performance
ACAD Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
$32.77 M
-$624.00 K-1.87%
September 30, 2024
Summary
- As of February 22, 2025, ACAD quarterly net profit is $32.77 million, with the most recent change of -$624.00 thousand (-1.87%) on September 30, 2024.
- Over the past year, ACAD quarterly net income has increased by +$97.94 million (+150.27%).
- ACAD quarterly net income is now -28.46% below its all-time high of $45.80 million, reached on December 31, 2023.
Performance
ACAD Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
$128.51 M
+$97.94 M+320.44%
September 30, 2024
Summary
- As of February 22, 2025, ACAD TTM net profit is $128.51 million, with the most recent change of +$97.94 million (+320.44%) on September 30, 2024.
- Over the past year, ACAD TTM net income has increased by +$277.31 million (+186.36%).
- ACAD TTM net income is now at all-time high.
Performance
ACAD TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ACAD Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +71.6% | +150.3% | +186.4% |
3 y3 years | +78.2% | +326.6% | +167.1% |
5 y5 years | +75.0% | +178.1% | +154.6% |
ACAD Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +71.6% | -28.5% | +129.0% | at high | +159.1% |
5 y | 5-year | at high | +78.2% | -28.5% | +129.0% | at high | +145.6% |
alltime | all time | -504.8% | +78.8% | -28.5% | +129.0% | at high | +141.5% |
ACADIA Pharmaceuticals Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $32.77 M(-1.9%) | $128.51 M(+320.4%) |
Jun 2024 | - | $33.39 M(+101.7%) | $30.57 M(-1887.4%) |
Mar 2024 | - | $16.55 M(-63.9%) | -$1.71 M(-97.2%) |
Dec 2023 | -$61.29 M(-71.6%) | $45.80 M(-170.3%) | -$61.29 M(-58.8%) |
Sep 2023 | - | -$65.18 M(-5950.6%) | -$148.81 M(+34.3%) |
Jun 2023 | - | $1.11 M(-102.6%) | -$110.81 M(-24.1%) |
Mar 2023 | - | -$43.02 M(+3.1%) | -$145.94 M(-32.4%) |
Dec 2022 | -$215.97 M(+28.7%) | -$41.73 M(+53.5%) | -$215.97 M(-0.6%) |
Sep 2022 | - | -$27.18 M(-20.1%) | -$217.34 M(+6.2%) |
Jun 2022 | - | -$34.01 M(-69.9%) | -$204.62 M(-4.6%) |
Mar 2022 | - | -$113.06 M(+162.3%) | -$214.48 M(+27.8%) |
Dec 2021 | -$167.87 M(-40.4%) | -$43.09 M(+198.1%) | -$167.87 M(-12.4%) |
Sep 2021 | - | -$14.46 M(-67.0%) | -$191.54 M(-26.8%) |
Jun 2021 | - | -$43.87 M(-34.0%) | -$261.74 M(+0.7%) |
Mar 2021 | - | -$66.45 M(-0.5%) | -$260.01 M(-7.7%) |
Dec 2020 | -$281.58 M(+19.7%) | -$66.76 M(-21.1%) | -$281.58 M(+5.1%) |
Sep 2020 | - | -$84.66 M(+100.9%) | -$267.86 M(+19.0%) |
Jun 2020 | - | -$42.14 M(-52.1%) | -$225.18 M(-5.4%) |
Mar 2020 | - | -$88.02 M(+66.0%) | -$237.98 M(+1.2%) |
Dec 2019 | -$235.26 M(-4.1%) | -$53.04 M(+26.3%) | -$235.26 M(-5.0%) |
Sep 2019 | - | -$41.98 M(-23.6%) | -$247.72 M(-7.5%) |
Jun 2019 | - | -$54.94 M(-35.6%) | -$267.88 M(-3.0%) |
Mar 2019 | - | -$85.30 M(+30.3%) | -$276.20 M(+12.6%) |
Dec 2018 | -$245.19 M(-15.3%) | -$65.49 M(+5.4%) | -$245.19 M(-1.4%) |
Sep 2018 | - | -$62.14 M(-1.8%) | -$248.57 M(-1.2%) |
Jun 2018 | - | -$63.27 M(+16.5%) | -$251.68 M(-1.6%) |
Mar 2018 | - | -$54.30 M(-21.2%) | -$255.86 M(-11.6%) |
Dec 2017 | -$289.40 M(+6.6%) | -$68.87 M(+5.6%) | -$289.40 M(-3.3%) |
Sep 2017 | - | -$65.25 M(-3.3%) | -$299.23 M(-2.1%) |
Jun 2017 | - | -$67.44 M(-23.2%) | -$305.59 M(-1.3%) |
Mar 2017 | - | -$87.84 M(+11.6%) | -$309.47 M(+14.0%) |
Dec 2016 | -$271.39 M(+65.0%) | -$78.70 M(+9.9%) | -$271.39 M(+13.8%) |
Sep 2016 | - | -$71.61 M(+0.4%) | -$238.48 M(+15.9%) |
Jun 2016 | - | -$71.32 M(+43.3%) | -$205.77 M(+18.4%) |
Mar 2016 | - | -$49.76 M(+8.7%) | -$173.83 M(+5.7%) |
Dec 2015 | -$164.44 M(+77.8%) | -$45.78 M(+17.7%) | -$164.44 M(+11.8%) |
Sep 2015 | - | -$38.91 M(-1.2%) | -$147.03 M(+10.6%) |
Jun 2015 | - | -$39.38 M(-2.5%) | -$132.91 M(+15.5%) |
Mar 2015 | - | -$40.38 M(+42.3%) | -$115.02 M(+24.4%) |
Dec 2014 | -$92.47 M(+143.7%) | -$28.37 M(+14.4%) | -$92.47 M(+21.4%) |
Sep 2014 | - | -$24.79 M(+15.3%) | -$76.16 M(+22.7%) |
Jun 2014 | - | -$21.50 M(+20.6%) | -$62.07 M(+25.0%) |
Mar 2014 | - | -$17.83 M(+48.0%) | -$49.65 M(+30.8%) |
Dec 2013 | -$37.95 M | -$12.05 M(+12.7%) | -$37.95 M(+16.0%) |
Sep 2013 | - | -$10.70 M(+17.8%) | -$32.71 M(+34.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2013 | - | -$9.08 M(+48.3%) | -$24.42 M(+17.6%) |
Mar 2013 | - | -$6.12 M(-10.1%) | -$20.75 M(-0.5%) |
Dec 2012 | -$20.85 M(-8.4%) | -$6.81 M(+183.5%) | -$20.85 M(+7.8%) |
Sep 2012 | - | -$2.40 M(-55.7%) | -$19.34 M(-12.1%) |
Jun 2012 | - | -$5.42 M(-12.8%) | -$22.01 M(-4.9%) |
Mar 2012 | - | -$6.22 M(+17.3%) | -$23.15 M(+1.7%) |
Dec 2011 | -$22.77 M(-250.4%) | -$5.30 M(+4.4%) | -$22.77 M(-295.0%) |
Sep 2011 | - | -$5.08 M(-22.6%) | $11.68 M(-6.8%) |
Jun 2011 | - | -$6.56 M(+12.4%) | $12.53 M(-15.3%) |
Mar 2011 | - | -$5.83 M(-120.0%) | $14.79 M(-2.3%) |
Dec 2010 | $15.14 M(-133.5%) | $29.14 M(-789.4%) | $15.14 M(-166.7%) |
Sep 2010 | - | -$4.23 M(-1.4%) | -$22.69 M(-16.6%) |
Jun 2010 | - | -$4.29 M(-21.9%) | -$27.19 M(-23.7%) |
Mar 2010 | - | -$5.49 M(-36.9%) | -$35.63 M(-21.1%) |
Dec 2009 | -$45.15 M(-29.7%) | -$8.69 M(-0.4%) | -$45.15 M(-10.5%) |
Sep 2009 | - | -$8.73 M(-31.4%) | -$50.42 M(-12.0%) |
Jun 2009 | - | -$12.73 M(-15.2%) | -$57.31 M(-8.8%) |
Mar 2009 | - | -$15.00 M(+7.4%) | -$62.87 M(-2.1%) |
Dec 2008 | -$64.24 M(+13.9%) | -$13.96 M(-10.6%) | -$64.24 M(-4.6%) |
Sep 2008 | - | -$15.61 M(-14.6%) | -$67.32 M(-0.6%) |
Jun 2008 | - | -$18.29 M(+11.6%) | -$67.75 M(+12.5%) |
Mar 2008 | - | -$16.38 M(-3.9%) | -$60.22 M(+6.8%) |
Dec 2007 | -$56.39 M(+25.2%) | -$17.04 M(+6.2%) | -$56.39 M(+8.9%) |
Sep 2007 | - | -$16.05 M(+49.2%) | -$51.80 M(+10.2%) |
Jun 2007 | - | -$10.75 M(-14.3%) | -$47.02 M(-2.3%) |
Mar 2007 | - | -$12.55 M(+0.8%) | -$48.13 M(+6.9%) |
Dec 2006 | -$45.05 M(+32.0%) | -$12.45 M(+10.5%) | -$45.05 M(+5.3%) |
Sep 2006 | - | -$11.26 M(-5.1%) | -$42.80 M(-2.4%) |
Jun 2006 | - | -$11.87 M(+25.4%) | -$43.84 M(+15.3%) |
Mar 2006 | - | -$9.47 M(-7.2%) | -$38.01 M(+11.4%) |
Dec 2005 | -$34.13 M(+31.7%) | -$10.20 M(-17.1%) | -$34.14 M(+9.2%) |
Sep 2005 | - | -$12.31 M(+103.8%) | -$31.27 M(+24.2%) |
Jun 2005 | - | -$6.04 M(+8.0%) | -$25.18 M(+0.6%) |
Mar 2005 | - | -$5.59 M(-23.8%) | -$25.02 M(-3.4%) |
Dec 2004 | -$25.92 M(+83.9%) | -$7.33 M(+18.0%) | -$25.92 M(+17.2%) |
Sep 2004 | - | -$6.21 M(+5.6%) | -$22.11 M(+13.9%) |
Jun 2004 | - | -$5.89 M(-9.2%) | -$19.41 M(+17.6%) |
Mar 2004 | - | -$6.48 M(+84.0%) | -$16.50 M(+22.9%) |
Dec 2003 | -$14.09 M(+9.5%) | -$3.52 M(0.0%) | -$13.43 M(+35.6%) |
Sep 2003 | - | -$3.52 M(+18.4%) | -$9.91 M(+55.2%) |
Jun 2003 | - | -$2.98 M(-12.7%) | -$6.39 M(+87.3%) |
Mar 2003 | - | -$3.41 M | -$3.41 M |
Dec 2002 | -$12.87 M(-10.7%) | - | - |
Dec 2001 | -$14.41 M(+41.3%) | - | - |
Dec 2000 | -$10.19 M | - | - |
FAQ
- What is ACADIA Pharmaceuticals annual net profit?
- What is the all time high annual net income for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual net income year-on-year change?
- What is ACADIA Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly net income year-on-year change?
- What is ACADIA Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals TTM net income year-on-year change?
What is ACADIA Pharmaceuticals annual net profit?
The current annual net income of ACAD is -$61.29 M
What is the all time high annual net income for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual net profit is $15.14 M
What is ACADIA Pharmaceuticals annual net income year-on-year change?
Over the past year, ACAD annual net profit has changed by +$154.69 M (+71.62%)
What is ACADIA Pharmaceuticals quarterly net profit?
The current quarterly net income of ACAD is $32.77 M
What is the all time high quarterly net income for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly net profit is $45.80 M
What is ACADIA Pharmaceuticals quarterly net income year-on-year change?
Over the past year, ACAD quarterly net profit has changed by +$97.94 M (+150.27%)
What is ACADIA Pharmaceuticals TTM net profit?
The current TTM net income of ACAD is $128.51 M
What is the all time high TTM net income for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high TTM net profit is $128.51 M
What is ACADIA Pharmaceuticals TTM net income year-on-year change?
Over the past year, ACAD TTM net profit has changed by +$277.31 M (+186.36%)